Alteration of lymphocyte opioid receptors in methadone maintenance subjects

Neurochemistry International

Volumn 56, Issue 2, 2010, Pages 285-290

  Toskulkao, Tipa ^a   Pornchai, Ruchee ^a   Akkarapatumwong, Varaporn ^a   Vatanatunyakum, Smith ^b   Govitrapong, Piyarat ^a,c  

^a MAHIDOL UNIVERSITY   (Thailand)

^b Thanyarak hospital   (Thailand)

^c Mahidol University   (Thailand)

Author keywords

Heroin abuse; Immune function; Lymphocyte; Methadone; Morphine; Naloxone; Opioid receptor

Indexed keywords

ACTIN; DELTA OPIATE RECEPTOR; DIAMORPHINE; G PROTEIN COUPLED RECEPTOR; LYMPHOCYTE SURFACE MARKER; MESSENGER RNA; METHADONE; MU OPIATE RECEPTOR; NALOXONE; OPIATE RECEPTOR; PERTUSSIS TOXIN; TRITIUM;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HEROIN DEPENDENCE; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNOCOMPETENT CELL; IN VITRO STUDY; LYMPHOCYTE CULTURE; LYMPHOCYTE PROLIFERATION; MALE; METHADONE TREATMENT; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION; RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

HEROIN; HUMANS; LYMPHOCYTES; METHADONE; OPIOID-RELATED DISORDERS; RECEPTORS, OPIOID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 77149127063     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2009.10.013     Document Type: Article

References (26)

1. Beaumont V., Handerson G. Relevance of proposed mechanisms of G-protein-coupled receptor desensitization to opioid receptors. Opioid Sensitivity of Chronic Noncancer Pain, Progress in Pain Research and Management 1999, vol. 14:59-81. IASP Press, Seattle.
2. Bohm S.K., Grady E.F., Bunnett N.W. Regulatory mechanisms that modulate signalling by G-protein-coupled receptors. Biochem. J. 1997, 322:1-18.
3. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
4. Carr D.J., Rogers T.J., Weber R.J. The relevance of opioids and opioid receptors on immunocompetence and immune homeostasis. Proc. Soc. Exp. Biol. Med. 1996, 213:248-257.
5. Chetsawang B., Casalotti S.O., Phansuwan-Pujito P., Kotchabhakdi N., Govitrapong P. Gene expressions of opioid receptors and G-proteins in pineal glands. Biochem. Biophys. Res. Commun. 1999, 262:775-780.
6. Dhawan B.N., Cesselin F., Raghubir R., Reisine T., Bradley P.B., Portoghese P.S., Hamon M. International Union of Pharmacology. XII. Classification of opioid receptors. Pharmacol. Rev. 1996, 48:567-592.
7. Fukuda K., Kato S., Morikawa H., Shoda T., Mori K. Functional coupling of the delta-, mu-, and kappa-opioid receptors to mitogen-activated protein kinase and arachidonate release in Chinese hamster ovary cells. J. Neurochem. 1996, 67:1309-1316.
8. Govitrapong P., Toskulkao T., Sutitum T., Akkarapatumwong V., Kotchabhakdi N., Vatanatunyakum S. Down-regulation of opioid receptor gene expressions in T lymphocyte of heroin abusers. Singapore Med. J. 2000, 41(Suppl.):45-48.
9. Govitrapong P., Suttitum T., Kotchabhakdi N., Uneklabh T. Alterations of immune functions in heroin addicts and heroin withdrawal subjects. J. Pharmacol. Exp. Therap. 1998, 286:883-889.
10. Knapp R.J., Malatynska E., Fang L., Li X., Babin E., Nguyen M., Santoro G., Varga E.V., Hruby V.J., Roeske W.R., Yamamura H.I. Identification of a human delta opioid receptor: clonning and expression. Life Sci. 1994, 54:463-469.
11. Kreek M.J. Immunological function in active heroin addicts and methadone-maintained former addicts: observations and possible mechanisms. NIDA Res. Monogr. 1990, 105:75-80.
12. Kreek M.J. Rationale for maintenance pharmacotherapy of opiate dependence. Addictive States 1992, 205-230. Raven Press, New York. C.P. O'Brien, J.H. Jaffe (Eds.).
13. Kreek M.J. Clinical update of opioid agonist and partial agonist medications for the maintenance treatment of opioid addiction. Sermin. Neurosci. 1997, 9:140-157.
14. Kreek M.J. Methadone-related opioid agonist pharmacotherapy for heroin addiction. History, recent molecular and neurochemical research and future in mainstream medicine. Ann. N. Y. Acad. Sci. 2000, 909:186-216.
15. Madden J.J., Donahoe R.M., Zwemer-Collins J., Shafer D.A., Falek A. Binding of naloxone to human T lymphocytes. Biochem. Pharmacol. 1987, 36:4103-4109.
16. Martin T.J., Kahn W.R., Xiao R., Childers S.R. Differential regional effects of methadone maintenance compared to heroin dependence on mu-opioid receptor desensitization in rat brain. Synapse 2007, 61:176-184.
17. McDonough R.J., Madden J.J., Falek A., Shafer D.A., Pline M., Gordon D., Bokos P., Kuehnle J.C., Mendelson J. Alteration of T and null lymphocyte frequencies in the peripheral blood of human opiate addicts: in vivo evidence for opiate receptor sites on T lymphocytes. J. Immunol. 1980, 125:2539-2543.
18. Mehrishi J.N., Mills H. Opiate receptors on lymphocytes and platelets in man. Clin. Immunol. Immunopathol. 1983, 27:240-249.
19. Mestek A., Hurley J.H., Bye .L.S., Campbell A.D., Chen Y., Tian M., Liu J., Schulman H., Yu L. The human mu opioid receptor: modulation of functional desensitization by calcium/calmodulin-dependent protein kinase and protein kinase C. J. Neurosci. 1995, 13:2396-2406.
20. Nielsen D.A., Yuferov V., Hamon S., Jackson C., Ho A., Ott J., Kreek M.J. Increased OPRM1 DNA methylation in lymphocytes of methadone-maintained former heroin addicts. Neuropsychopharmacology 2009, 34:867-873.
21. Ovadia H., Nitsan P., Abramsky O. Characterization of opiate binding sites on membranes of rat lymphocytes. J. Neuroimmunol. 1989, 21:93-102.
22. Peterson P.K., Molitor T.W., Chao C.C. Mechanisms of morphine-induced immunomodulation. Biochem. Pharmacol. 1993, 46:343-348.
23. Quagliata F., Melton R., Soika I. Decrease response to mitogens and impaired capping ability of lymphocytes in narcotic addiction. Clin. Res. 1977, 25:513A.
24. Rouveix B. Opiates and immune function. Consequences on infectious diseases with special reference to AIDS. Therapie 1992, 47:503-512.
25. Sharp B.M. Opioid receptor expression and intracellular signaling by cells involved in host defense and immunity. Adv. Exp. Med. Biol. 2003, 521:98-105.
26. Wu T., Li X.Y. Evidence for mu opioid receptor on mouse spleen lymphocyte. Acta Pharmacol. Sinica 1999, 20:835-843.